A critical breakthrough in cancer investigation is arising with the use of nanobodies to reactivate dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in many forms of malignancies, https://monobookmarks.com/story21836446/nanobodies-revive-p53-new-new-hope-for-tumor-treatment